Figure 3.
A/L ratio at EOI. A/L ratio is a sensitive measure for insulin sensitivity and healthy adipocytes. A/L ratio at EOI was higher for both lean and OW/OB patients treated in the IDEAL trial as compared with the historical control. **Significant at 2-sided P < .01.